DE60023870T2 - Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte - Google Patents

Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte Download PDF

Info

Publication number
DE60023870T2
DE60023870T2 DE60023870T DE60023870T DE60023870T2 DE 60023870 T2 DE60023870 T2 DE 60023870T2 DE 60023870 T DE60023870 T DE 60023870T DE 60023870 T DE60023870 T DE 60023870T DE 60023870 T2 DE60023870 T2 DE 60023870T2
Authority
DE
Germany
Prior art keywords
aryloxy
preparation
arylpropylamine
intermediate products
arylpropylamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023870T
Other languages
English (en)
Other versions
DE60023870D1 (de
Inventor
Patton Kjell
Thomas Lorenz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60023870D1 publication Critical patent/DE60023870D1/de
Publication of DE60023870T2 publication Critical patent/DE60023870T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Pyrrole Compounds (AREA)
DE60023870T 1999-04-09 2000-03-22 Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte Expired - Lifetime DE60023870T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12848099P 1999-04-09 1999-04-09
PCT/US2000/006423 WO2000061540A1 (en) 1999-04-09 2000-03-22 Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof

Publications (2)

Publication Number Publication Date
DE60023870D1 DE60023870D1 (de) 2005-12-15
DE60023870T2 true DE60023870T2 (de) 2006-06-14

Family

ID=22435565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023870T Expired - Lifetime DE60023870T2 (de) 1999-04-09 2000-03-22 Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte

Country Status (10)

Country Link
US (1) US6541668B1 (de)
EP (1) EP1171417B1 (de)
JP (1) JP2002541235A (de)
AT (1) ATE309196T1 (de)
AU (1) AU3877500A (de)
CA (1) CA2362185C (de)
DE (1) DE60023870T2 (de)
DK (1) DK1171417T3 (de)
ES (1) ES2249256T3 (de)
WO (1) WO2000061540A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157779A0 (en) 2001-03-06 2004-03-28 Lilly Co Eli Inhibitor of monoamine uptake
US20040249170A1 (en) * 2002-01-24 2004-12-09 Alfio Borghese Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
EP1708717B1 (de) * 2003-07-28 2011-10-05 Leslie Joe Dunaway Atomoxetin zur Behandlung von allergischer Rhinitis und Asthma
US20050197503A1 (en) * 2004-03-05 2005-09-08 Boehringer Ingelheim International Gmbh Process for the preparation of N-alkyl-N-methyl-3-hydroxy-3-(2-thienyl)-propylamines
EP1687254A2 (de) * 2004-06-28 2006-08-09 Teva Pharmaceutical Fine Chemicals S.R.L. Verfahren zur optischen trennung und rückgewinnung von tomoxetin
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
EP1768949A2 (de) * 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphe von atomoxetien-hydrochlorid
US7550605B2 (en) * 2004-08-05 2009-06-23 Sun Pharmaceutical Industries Ltd. Process for preparation of an anitdepressant compound
US20080004470A1 (en) * 2004-09-27 2008-01-03 Mathad Vijayavitthal T Synthesis of Atomoxetine Hydrochloride
US20060194869A1 (en) * 2004-12-23 2006-08-31 Santiago Ini Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
EP1856087A1 (de) * 2005-03-08 2007-11-21 Teva Pharmaceutical Industries Limited Kristallformen von (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamin-oxalat und deren herstellung
CA2599478A1 (en) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Process for the purification of duloxetine hydrochloride
EP1889828A1 (de) * 2005-04-05 2008-02-20 Teva Pharmaceutical Fine Chemicals S.R.L. Stabiles Atomoxetinhydrochlorid, Herstellungsverfahren und analytische Steuerung seiner Stabilität
JP2008501721A (ja) * 2005-04-05 2008-01-24 テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
US7485754B2 (en) * 2005-07-08 2009-02-03 Apotex Pharmachem Inc. Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
CZ296345B6 (cs) * 2005-07-21 2006-02-15 Zentiva, A. S Zpusob výroby hydrochloridu (R)-N-methyl-3-(2-methylfenoxy)-3-fenylpropylaminu (atomoxetinu)
US20080207923A1 (en) * 2005-09-22 2008-08-28 Santiago Ini Pure DNT-maleate and methods of preparation thereof
US7842717B2 (en) 2005-09-22 2010-11-30 Teva Pharmaceutical Industries Ltd. DNT-maleate and methods of preparation thereof
US7759500B2 (en) * 2005-12-05 2010-07-20 Teva Pharmaceutical Industries Ltd. 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
US20090221668A1 (en) 2005-12-12 2009-09-03 Medichem, S.A. Synthesis and preparations of duloxetine salts
EP1798215A1 (de) * 2005-12-14 2007-06-20 SOLMAG S.p.A. Polymorph von Atomoxetin-hydrochloride in kristalliner Form
US7538232B2 (en) 2006-01-19 2009-05-26 Eli Lilly And Company Process for the asymmetric synthesis of duloxetine
MX2007011611A (es) * 2006-01-23 2007-10-18 Teva Pharma Fumarato de dnt y metodos de preparacion de ellos.
MX2007011727A (es) * 2006-01-23 2007-11-15 Teva Pharma Dnt-succinato y metodos de preparacion de el.
CA2640212A1 (en) * 2006-02-13 2007-08-23 Teva Pharmaceutical Industries Ltd. A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
EP1888554A2 (de) * 2006-02-21 2008-02-20 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von (s)-(-)-n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamin, einem duloxetin-zwischenprodukt
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
MX2008001079A (es) * 2006-05-23 2008-03-19 Teva Pharma Polimorfos de hidrocloruro de duloxetina.
EP1976846A2 (de) * 2006-05-31 2008-10-08 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von duloxetin und vermittler davon
CN100430370C (zh) * 2006-11-03 2008-11-05 华东理工大学 一种丙胺衍生物及其在制备托莫西汀中的应用
US20080145318A1 (en) * 2006-12-13 2008-06-19 Midha Kamal K Atomoxetine formulations and associated methods
ATE552250T1 (de) 2006-12-22 2012-04-15 Synthon Bv Verfahren zur herstellung von duloxetin und verwandten verbindungen
WO2008107911A2 (en) * 2007-03-05 2008-09-12 Lupin Limited Novel process for preparation of duloxetine hydrochloride
WO2009019719A2 (en) * 2007-08-09 2009-02-12 Ind-Swift Laboratories Limited Process for the preparation of 3-aryloxy-3-arylpropanamines
EP2060559A1 (de) 2007-11-19 2009-05-20 Cadila Pharmaceuticals Limited Herstellungsverfahren für enantiomerenreine 3-Hydroxy-3-Arylpropylamine und ihrer optischen Stereoisomere
US20100267968A1 (en) * 2007-12-26 2010-10-21 Orchid Chemicals & Pharmaceuticals Limited Method for the preparation of duloxetine hydrochloride
AU2009206204B2 (en) * 2008-01-25 2015-03-19 Alphapharm Pty Ltd Delayed release pharmaceutical composition of duloxetine
WO2009141833A2 (en) * 2008-04-17 2009-11-26 Ind-Swift Laboratories Limited An improved process for synthesizing highly pure atomoxetine
WO2010025287A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
US8426178B2 (en) 2008-08-27 2013-04-23 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
EP2558455B1 (de) 2010-04-13 2017-08-09 KRKA, D.D., Novo Mesto Synthese von duloxetin- und/oder pharmazeutisch akzeptablen salzen daraus
CN102863344B (zh) * 2012-07-20 2015-06-03 葫芦岛国帝药业有限责任公司 一种托莫西汀药物制备方法
CN106916074A (zh) * 2017-02-14 2017-07-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN108929236A (zh) * 2017-05-26 2018-12-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN110294680A (zh) * 2018-03-22 2019-10-01 北京深蓝海生物医药科技有限公司 一种盐酸阿托莫西汀的制备方法
CN111302958B (zh) * 2020-03-24 2023-05-02 合肥医工医药股份有限公司 一种光学纯的（r）-n-甲基-3-苯基-3-（邻-甲苯氧基）-丙胺盐酸盐制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77018C (fi) 1980-11-14 1989-01-10 Lilly Co Eli Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
JPS6023656A (ja) 1983-07-20 1985-02-06 Nissan Motor Co Ltd 自動変速機の遊星歯車列
US4868344A (en) 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
FI81083C (fi) * 1989-03-03 1990-09-10 Orion Yhtymae Oy Ett foerbaettrat foerfarande foer framstaellning av n-metyl-3-(p-trifluormetylfenoxi)-3-fenylpropylamin hydroklorid.
US5104899A (en) 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
ES2120368B1 (es) * 1996-06-14 1999-07-01 Almirall Prodesfarma Sa Procedimiento de obtencion de n-metil-3-(p-trifluorometilfenoxi)-3-fenilpropilamina y sus sales farmaceuticamente aceptables.
IT1283141B1 (it) * 1996-07-11 1998-04-07 Laporte Organics Francis S P A Procedimento per la preparazione di n-metil-3-(p-trifluorometilfenossi)-3-fenilpropilamina e dei suoi
TW514634B (en) 1997-10-14 2002-12-21 Lilly Co Eli Process to make chiral compounds

Also Published As

Publication number Publication date
WO2000061540A1 (en) 2000-10-19
EP1171417B1 (de) 2005-11-09
ES2249256T3 (es) 2006-04-01
CA2362185C (en) 2009-06-02
US6541668B1 (en) 2003-04-01
DK1171417T3 (da) 2006-02-20
AU3877500A (en) 2000-11-14
DE60023870D1 (de) 2005-12-15
EP1171417A1 (de) 2002-01-16
JP2002541235A (ja) 2002-12-03
CA2362185A1 (en) 2000-10-19
ATE309196T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
DE60023870T2 (de) Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte
ATE296116T1 (de) Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie
TR200200068T2 (tr) Nematisital triflüorobütenler
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
EE200000318A (et) Uudsed ühendid
DE69942641D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
SE9802729D0 (sv) Novel Compounds
DE69509843D1 (de) Apparat zur Behandlung z.B. von Poststücken
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
DE69923906D1 (de) Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon
DE60328502D1 (de) Verfahren zur herstellung von 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazolen aus cyclohexanen und cycylohexanonen als zwischenprodukte
DE69809828D1 (de) Verfahren zur Herstellung von Nudeln
DE60017341D1 (de) Emulsion, und Verfahren zur Herstellung von Emulsionen und öligen Zusammensetzungen
DE59900916D1 (de) Verfahren zur Herstellung von 4-Aminodiphenylamin
DE69821053T2 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidyl-Gruppen enthaltenden Polytriazinen
IT1314768B1 (it) Processo per la produzione di additivi antifiamma per composizionipolimeriche,e prodotti ottenuti da detto processo
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
ATE339437T1 (de) 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
DE60022565D1 (de) Verfahren zur Herstellung von Polyaminzusammensetzungen
DE50005182D1 (de) Verfahren zur adiabatischen Herstellung von 3,4-Dichlornitrobenzol
DE59300883D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin und dessen Chlorierungsprodukten.
DE69802329D1 (de) Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69817743D1 (de) Verfahren zur Herstellung von aromatischen Nitrilen
DE69812160D1 (de) Verfahren und zwischenprodukte zur herstellung von triazolin herbiziden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN